Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma

Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma

BackgroundIn this study, we evaluated the prognostic value of the plasma levels of Epstein-Barr virus (EBV) DNA in patients with nasopharyngeal carcinoma (NPC) at different treatment stages.MethodsWe retrospectively analyzed the Data of 206 patients with NPC. Pre-neoadjuvant chemotherapy (pre-NACT),...

Full description

Bibliographic Details
Main Authors: Lisheng Zhu, Tao Ouyang, Ying Xiong, Li Ba, Qiuting Li, Mengjun Qiu, Zhenwei Zou, Gang Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
nasopharyngeal carcinoma
Epstein-Barr virus DNA
neoadjuvant chemotherapy
prognostic factor
nomogram
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.714433/full

Similar Items

Similar Items